The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(1,2,3,5,6,7-hexahydros-indacen-4-ylcarbamoyl)-2-(pyridin-2-yl)ethenesulfonamide ID: ALA4744515
PubChem CID: 137537344
Max Phase: Preclinical
Molecular Formula: C20H21N3O3S
Molecular Weight: 383.47
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Nc1c2c(cc3c1CCC3)CCC2)NS(=O)(=O)/C=C/c1ccccn1
Standard InChI: InChI=1S/C20H21N3O3S/c24-20(23-27(25,26)12-10-16-7-1-2-11-21-16)22-19-17-8-3-5-14(17)13-15-6-4-9-18(15)19/h1-2,7,10-13H,3-6,8-9H2,(H2,22,23,24)/b12-10+
Standard InChI Key: DMRMAAFXWJCCEI-ZRDIBKRKSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
17.2807 -10.5244 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.6934 -11.2384 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
18.1060 -10.5219 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.5428 -11.2408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9618 -10.4135 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5439 -10.4171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2514 -10.0097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0771 -9.2108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2645 -9.1269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9351 -9.8740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9646 -11.2403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2601 -11.6542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4321 -12.4550 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2471 -12.5376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5761 -11.7878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8312 -11.6539 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.1191 -11.2416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4075 -11.6547 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.1186 -10.4203 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.9838 -11.6555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2696 -11.2471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5643 -11.6640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8512 -11.2524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1423 -11.6687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1467 -12.4909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8660 -12.8950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5720 -12.4805 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
6 4 2 0
4 12 1 0
11 5 1 0
5 7 2 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 6 1 0
11 12 2 0
12 13 1 0
13 14 1 0
14 15 1 0
15 11 1 0
4 16 1 0
16 17 1 0
17 18 1 0
17 19 2 0
18 2 1 0
2 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 383.47Molecular Weight (Monoisotopic): 383.1304AlogP: 3.18#Rotatable Bonds: 4Polar Surface Area: 88.16Molecular Species: ACIDHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.29CX Basic pKa: 4.56CX LogP: 2.77CX LogD: 2.79Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.85Np Likeness Score: -0.94
References 1. Agarwal S,Pethani JP,Shah HA,Vyas V,Sasane S,Bhavsar H,Bandyopadhyay D,Giri P,Viswanathan K,Jain MR,Sharma R. (2020) Identification of a novel orally bioavailable NLRP3 inflammasome inhibitor., 30 (21.0): [PMID:32980515 ] [10.1016/j.bmcl.2020.127571 ]